Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria

Journal of Neurology

Volumn 259, Issue 11, 2012, Pages 2429-2433

  Renard, Dimitri ^a   Castelnovo, Giovanni ^a   Wacongne, Anne ^a   Le Floch, Anne ^a   Thouvenot, Eric ^a   Mas, Julie ^a   Gabelle, Audrey ^b,c   Labauge, Pierre ^a   Lehmann, Sylvain ^c  

^a DEPARTMENT OF NEUROLOGY   (France)

^b GUI DE CHAULIAC HOSPITAL   (France)

^c INSERM   (France)

Author keywords

A 40; A 42; Cerebral amyloid angiopathy; CSF biomarkers; Lobar hematoma; P tau; Superficial siderosis; T tau

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN HEMATOMA; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; MALE; MODIFIED BOSTON CRITERIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDEROSIS; VASCULAR AMYLOIDOSIS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; CEREBRAL AMYLOID ANGIOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; TAU PROTEINS;

EID: 84868195354     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6520-8     Document Type: Article

References (14)

1. Knudsen KA, Rosand J, Karluk D, Greenberg SM (2001) Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 56:537-539 (Pubitemid 32172884)
2. Verbeek MM, Kremer BP, Rikkert MO et al (2009) Cerebro-spinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy. Ann Neurol 66:245-249
3. Hansson O, Zetterberg H, Buchhave P et al (2006) Association between CSF biomarkers and incipient Alzheimer' disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 5:228-234 (Pubitemid 43238346)
4. Vemuri P, Wiste HJ, Weigand SD et al (2009) Alzheimer disease neuroimaging initiative. MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. Neurology 73:287-293
5. Goos JD, Teunissen CE, Veerhuis R et al. (2011) Microbleeds relate to altered amyloid-beta metabolism in Alzheimer's disease. Neurobiol Aging 33:1011.e1-1011.e9
6. Linn J, Halpin A, Demearel P et al (2010) Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 74:1346-1350
7. van Rooden S, van der Grond J, van den Boom R et al (2009) Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population. Stroke 40:3022-3027
8. Bateman RJ, Munsell LY, Morris JC, Swarm R, Yarasheski KE, Holtzman DM (2006) Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nat Med 12:856-861 (Pubitemid 44050079)
9. Conover WJ (1999) Practical nonparametric statistics, 3rd edn. Wiley, New York
10. Bibl M, Mollenhauer B, Esselmann H et al (2006) CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia. Brain 129:1177-1187
11. Pijnenburg YA, Schoonenboom SN, Mehta PD et al (2007) Decreased cerebrospinal fluid amyloid beta (1-40) levels in frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry 78:735-737 (Pubitemid 46998847)
12. Gabelle A, Roche S, Gény C et al (2011) Decreased sAβPPβ, Aβ38, and Aβ40 cerebrospinal fluid levels in frontotemporal dementia. J Alzheimer Dis 26:553-563
13. Dubois B, Feldman HH, Jacova C et al (2007) Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734-746 (Pubitemid 47058377)
14. Hernandez-Guillamon M, Delgado P, Penalba A et al. (2012) Plasma β-amyloid levels in cerebral amyloid angiopathy-associated hemorrhagic stroke. Neurodegener Dis 10:320-323